Main Article Content

Abstract

Coronavirus disease 2019 (covid‐19) has become a major global crisis. preliminary reports have, in general, indicated worse outcomes in diabetes mellitus (dm) patients, but the magnitude of cardiovascular (cv) complications in this subgroup has not been elucidated.

Keywords

COVID-19 Al-Wakeel foundings cellular hypoxia cytokine release,immune system dysregulation

Article Details

How to Cite
Nazira, K., Siddikovna, T. G., Davranovna, D. A., Takhirovich, D. A., & Tulkinovich, O. S. (2021). Cardiovascular complications in patients who have had covid on the background of diabetes mellitus 2. Central Asian Journal of Medical and Natural Science, 2(3), 37-41. https://doi.org/10.17605/cajmns.v2i3.171

References

  1. [1] Beckman JA, Bikdeli B, Biondi‐Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID‐19 Pandemic. J Am Collardiol. 2020;
  2. [2] Cao B, Chen H, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;
  3. [3] Anikhindi S A, Arora A, Bansal N, et al. Is diabetes mellitus associated with mortality and severity of COVID‐19? A meta‐analysis. Diabet Metabol Synd Clinic Res Rev. 2020;
  4. [4] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018).
  5. [5] Chang A, Cheng P, Davis MM, et al. Cardiovascular complications in patients with COVID‐19: Consequences of viral toxicities and host immune response. Curr Cardiol Rep. 2020;
  6. [6] Dong K, Ren H, Shi X, et al. Clinical characteristics and outcomes of patients with severe covid‐19 with diabetes. BMJ Open Diabet Res Care. 2020;
  7. [7] Alwakeel JS, Sulimani R, Al-Asaad H, et al. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med. 2008.